Expression and immunogenicity assessment of a plant-made immunogen targeting the cytotoxic T-lymphocyte associated antigen-4: a possible approach for cancer immunotherapy
Reading Time: < 1 minute
Year: 2021
Plant-produced recombinant SARS-CoV-2 receptor-binding domain; an economical, scalable biomaterial source for COVID-19 diagnosis
Reading Time: < 1 minute
Plant-produced SARS-CoV-2 receptor binding domain (RBD) variants showed differential binding efficiency with anti-spike specific monoclonal antibodies
Reading Time: < 1 minute
Potential for Developing Plant-Derived Candidate Vaccines and Biologics against Emerging Coronavirus Infections
Reading Time: < 1 minute
Immunogenicity Studies of Plant-Produced SARS-CoV-2 Receptor Binding Domain-Based Subunit Vaccine Candidate with Different Adjuvant Formulations
Reading Time: < 1 minute
Functional Characterization of Pembrolizumab Produced in Nicotiana benthamiana Using a Rapid Transient Expression System
Reading Time: < 1 minute
Plant-Produced Receptor-Binding Domain of SARS-CoV-2 Elicits Potent Neutralizing Responses in Mice and Non-human Primates
Reading Time: < 1 minute
Biotechnological Insights on the Expression and Production of Antimicrobial Peptides in Plants
Reading Time: < 1 minute